Peltz's Trian urges Solventum to rightsize costs, divest non-core businesses

Nelson Peltz's Trian Fund Management on Thursday called on Solventum to rightsize overhead costs, ​divest non-core businesses and improve capital allocation in its ‌latest appeal for a performance turnaround at the medical device maker.